Chugai Expands Antibody Agreement With Tokyo-based Choime Bioscience
This article was originally published in PharmAsia News
Executive Summary
Chugai Pharmaceutical expanded an antibody identification agreement with Tokyo-based biotech venture Choime Bioscience